Effects of tranexamic acid on maternal outcomes among women stratified by placenta accreta spectrum grade: A 10-year single-centre retrospective cohort study
Year: 2026
Type: preprint
Study design: Observational Study
Abstract: Background To evaluate whether tranexamic acid (TXA) administration improves maternal outcomes by reducing postpartum estimated blood loss (EBL) and shortening the postpartum length of stay among women with different placenta accreta spectrum (PAS) grades. Methods This retrospective cohort study included 451 patients with PAS who delivered at a municipal critical maternity care centre from January 2015 to January 2026. Propensity score matching (PSM) based on TXA administration yielded 215 matched pairs in the overall cohort. The 451 patients were further stratified by whether they had an abnormally adherent or abnormally invasive placenta, yielding 87 and 108 matched pairs, respectively. The primary outcomes were 2- and 24-hour postpartum EBL; the secondary outcomes included severe postpartum haemorrhage (sPPH), postpartum length of stay, the need for allogeneic blood transfusion and the need for blood conservation measures. Subgroup analyses were performed to evaluate the effects of TXA across patients with PAS of different grades, and interaction effects between the PAS grade and TXA administration were assessed. Results In the overall matched cohort, TXA administration was associated with significantly lower 2- and 24-hour postpartum EBL and a lower incidence of EBL > 1500 mL ( P < 0.05). The rates of arterial embolization, intrauterine balloon tamponade, and salvaged autologous blood transfusion were also lower with TXA administration ( P < 0.05), whereas the rates of red blood cell and fresh frozen plasma transfusions did not significantly differ ( P > 0.05). In patients with an abnormally adherent or abnormally invasive placenta, TXA administration reduced 2-hour EBL (mean difference [MD], − 203.45 and − 347.22 mL, respectively) and 24-hour EBL (MD, − 290.35 and − 442.59 mL, respectively). Furthermore, among patients with an abnormally invasive placenta, TXA administration was associated with a lower incidence of EBL > 1500 mL (odds ratio [OR], 0.53; 95% confidence interval [CI], 0.31 to 0.91; P = 0.021) and a shorter postpartum length of stay (MD, − 0.93; 95% CI, − 1.49 to − 0.29; P = 0.004). A significant interaction was observed between the PAS grade and TXA administration for the postpartum length of stay ( P for interaction = 0.041). Conclusions In parturients with PAS, intrapartum TXA administration is associated with reduced postpartum EBL and sPPH incidence. Moreover, the depth of placental invasion significantly modifies the effect of TXA administration on the postpartum length of stay, with high-risk patients with an abnormally invasive placenta requiring a significantly shorter postpartum length of stay.
Source: Research Square
Institutions: Shanghai Jiao Tong University, People’s Hospital of Rizhao
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7236000774
